Enzo Health Funding Round Raises $20M For Home Health AI Solutions

LEHI, Utah—Enzo Health, the AI-driven platform for home health and post-acute care, announced its $20M Series A funding round, led by N47, bringing the company’s total funding to $26M. Existing investors Gradient, Tandem Ventures and Rigby Watts also participated.

Enzo’s AI-driven platform automates and connects home health and post-acute care providers’ front office, clinical operations and back office functions in one system, handling the entire workflow from referral to reimbursement while minimizing regulatory risk. 

Launched in 2024, Enzo Health is now used by organizations that support more than 500,000 patients annually.

“Home health is one of the fastest-growing segments in healthcare due to the rapidly expanding 65+ demographic,” said Zach Newman, co-founder and CEO of Enzo. “But the agencies delivering that care are being squeezed from every direction. Their compliance and operational requirements keep growing, while the solutions they’re using were never built to handle these demands. The result is burned-out clinicians, unsustainable turnover and patients who can’t get the care they need. Enzo fixes that.”

Seven out of 10 Americans will require long-term care at some point in their lifetime, according to the U.S. Department of Health and Human Services. With 73 million baby boomers increasingly gravitating toward home health, jobs in the sector are expected to grow by roughly 17% from 2024 to 2034, according to the Bureau of Labor Statistics.

Unfortunately, Medicare reimbursement cuts, tougher regulations, workforce shortages and shrinking margins have made it difficult for home health agencies to meet that demand. According to the Home Care Association of America, home health clinician turnover hovers near 80% within the first 100 days, as nurses and clinicians are frequently forced to work long hours to keep up with documentation for billing, regulatory compliance and quality assurance at the same time as they care for patients.

Enzo’s AI-driven platform aims to address these challenges by streamlining home health providers’ core workflows, connecting and automating the following in one system:

• Enzo Intake analyzes referrals instantly, converts faxes, emails and PDFs into structured data, and checks eligibility in seconds before staff review is needed
• Enzo Scribe delivers OASIS validation and AI-assisted documentation in real-time during a visit, so clinicians finish charting before they leave the patient’s home
• Enzo QA continuously reviews charts for clinical and regulatory accuracy, catching issues before they affect reimbursement or compliance
• Enzo Health plans to use part of the funds from its Series A to expand into the skilled nursing and hospice sectors by extending its AI-driven platform to address the unique clinical, operational and regulatory workflows of each setting, enabling providers to operate more efficiently while maintaining high-quality care.